Cell Therapy: A New M&A Frontier Middle Market Growth Conversations podcast

Artwork

Business Middle Market Middle Market Growth Middle Market Growth Magazine

Innehåll tillhandahållet av Middle Market Growth and Middle Market Growth Magazine. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Middle Market Growth and Middle Market Growth Magazine eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Middle Market Growth Conversations « »
Cell Therapy: A New M&A Frontier

1y ago 12:33

Dela

MP3•Episod hem

Innehåll tillhandahållet av Middle Market Growth and Middle Market Growth Magazine. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Middle Market Growth and Middle Market Growth Magazine eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Cell and gene therapy technologies are ascendent, boosted by new developments in treatments for diseases like ovarian cancer and Parkinson’s disease, and by predictions of a meteoric rise in total market value in the next five years. Fabian Gerlinghaus, the co-founder and CEO of Cellares, a company that has developed a so-called “factory-in-a-box” for cell and gene therapy manufacturing, joins the podcast to share Cellares’ unique approach to developing successful cell therapies, the regulatory landscape and why investors should be watching this sector. *** The Middle Market Growth Conversations podcast is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.

… continue reading

146 episoder

#Business #Middle Market #Middle Market Growth #Middle Market Growth Magazine

Artwork

Cell Therapy: A New M&A Frontier

Middle Market Growth Conversations

13 subscribers

published 1y ago

Dela

MP3•Episod hem

Innehåll tillhandahållet av Middle Market Growth and Middle Market Growth Magazine. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Middle Market Growth and Middle Market Growth Magazine eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Cell and gene therapy technologies are ascendent, boosted by new developments in treatments for diseases like ovarian cancer and Parkinson’s disease, and by predictions of a meteoric rise in total market value in the next five years. Fabian Gerlinghaus, the co-founder and CEO of Cellares, a company that has developed a so-called “factory-in-a-box” for cell and gene therapy manufacturing, joins the podcast to share Cellares’ unique approach to developing successful cell therapies, the regulatory landscape and why investors should be watching this sector. *** The Middle Market Growth Conversations podcast is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.

… continue reading

146 episoder

#Business #Middle Market #Middle Market Growth #Middle Market Growth Magazine

Alla avsnitt

×

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

Lyssna på 500+ ämnen